美国成人心脏移植术后生存风险评分开发
基于美国器官共享网络登记数据,开发并验证了预测成人心脏移植术后1年生存的US-TRS风险评分。该评分在测试集中c-index为0.671,优于French-TRS、IMPACT评分及等待名单状态,可识别17%的高风险受者(估计1年生存率78%)。
要点
- US-TRS包含受者年龄、胆红素、eGFR、白蛋白、 durable LVAD、糖尿病、机械通气、先心病及供者年龄、性别和大小匹配等变量。
- 测试集c-index为0.671,高于French-TRS的0.620、IMPACT的0.598和等待名单状态的0.551。
- 17%的受者被归为高风险,估计1年生存概率78%,平均RMST 311.9天。
核心结论
- US-TRS多变量风险评分在预测美国成人心脏移植术后1年生存方面优于现有模型,可能有助于将术后生存整合到连续分配框架中。
主要发现
- 队列共9,071例受者,平均年龄54岁(SD 13),72%男性,1年内死亡828例(9.1%),再移植29例(0.3%)。
- US-TRS模型包含受者年龄、胆红素、eGFR、白蛋白、 durable LVAD、糖尿病、机械通气、先天性心脏病、供者年龄、供者性别及供受者大小不匹配。
- 测试集c-index:US-TRS 0.671(95% CI 0.665-0.687),French-TRS 0.620(95% CI 0.611-0.632),IMPACT 0.598,等待名单状态0.551(95% CI 0.540-0.576)。
- 17%的受者为高风险,估计1年生存概率78%,平均估计RMST 311.9天。
关键数值与推荐
- US-TRS包含8个French-TRS组分中的8个,并加入改善AIC的美国变量。
- 测试集评估采用Uno的c-index和限制平均生存时间(RMST)。
临床怎么用
- US-TRS可用于识别心脏移植术后1年死亡高风险受者,辅助避免无效移植,并可能整合入连续分配系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the US, donor hearts for transplant are currently allocated to the candidates with the highest risk of death on the waiting list, based on a categorical status-based system. The upcoming continuous distribution system provides an opportunity to implement a post-transplant risk score that may help avoid futile transplants. METHODS: In this observational study of the Scientific Registry of Transplant Recipients (SRTR), a novel US transplant risk score (US-TRS) was developed and validated using a mixed-effects Cox proportional hazards model. Study participants included adult heart transplant recipients between October 18, 2018, and February 28, 2022, split temporally into training (first 70% of recipients) and test (last 30% of recipients) datasets. We included 8 of 9 French Transplant Risk Score (French-TRS) components plus additional US variables that improved the Akaike Information Criterion (AIC) in the training data. In the test dataset, we assessed US-TRS 1-year post-transplant survival predictions with Uno's concordance index (c-index) and restricted mean survival time (RMST) and compared these results to other post-transplant risk scores, including the French-TRS, the Index for Mortality Prediction After Cardiac Transplantation (IMPACT) score, and recipients' waitlist status at transplantation. RESULTS: The study cohort consisted of 9,071 heart transplant recipients (mean age 54 [SD 13] years, 72% male), of which 828 (9.1%) died and 29 (0.3%) underwent retransplant within 1 year of transplant. The final US-TRS model included recipient age, bilirubin, estimated glomerular filtration rate (eGFR), albumin, durable left ventricular assist device (LVAD), diabetes, mechanical ventilation, congenital heart disease, donor age, donor sex, and donor-recipient size mismatch. The c-index in the test dataset was 0.671 (95% CI, 0.665-0.687) for the US-TRS model, 0.620 (95% CI, 0.611-0.632) for the French-TRS model, 0.598 for the calculated IMPACT score, and 0.551 (95% CI, 0.540-0.576) for waitlist Status at transplant. US-TRS estimated excellent survival for most recipients, but a minority (17%) of recipients were high risk with an estimated 1-year survival probability of 78% and an average estimated RMST of 311.9 days in the first year. CONCLUSIONS: In this registry-based study of US adult heart transplant recipients, a multivariable risk score outperformed existing models in predicting 1-year post-transplant survival and may be useful for integrating post-transplant survival into the upcoming continuous distribution framework.
引用
- Lazenby KA, Tolmie SB, Barrett K, et al. Development of a risk score predicting survival after adult heart transplantation in the United States. J Heart Lung Transplant. 2025. PMID: 40691955. doi:10.1016/j.healun.2025.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。